{
  "DOI": "10.1186/s40246-021-00365-w",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-021-00365-w",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eBreast cancer (BC) is the most commonly diagnosed cancer and the second leading cause of cancer-related deaths among women in Africa after cervical cancer. Even if the epidemiological data are now aligned with those relating to industrialized countries, the knowledge concerning breast cancer in Africa, particularly in Western Africa, still lack clinical data, medical treatments, and the evaluation of genetic and non-genetic factors implicated in the etiology of the disease. The early onset and the aggressiveness of diagnosed breast cancers in patients of African ancestry strongly suggest that the genetic risk factor may be a key component, but so far, very few studies on the impact of germ line mutations in breast cancer in Africa have been conducted, with negative consequences on prevention, awareness and patient management. Through Next Generation sequencing (NGS), we analyzed all of the coding regions and the exon–intron junctions of \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e and \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e genes—the two most important genes in hereditary breast cancer—in fifty-one women from Burkina Faso with early onset of breast cancer with or without a family history.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe identified six different pathogenic mutations (three in \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e, three in \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e), two of which were recurrent in eight unrelated women. Furthermore, we identified, in four other patients, two variants of uncertain clinical significance (VUS) and two variants never previously described in literature, although one of them is present in the dbSNP database.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eThis is the first study in which the entire coding sequence of \u003cjats:italic\u003eBRCA\u003c/jats:italic\u003e genes has been analyzed through Next Generation Sequencing in Burkinabe young women with breast cancer. Our data support the importance of genetic risk factors in the etiology of breast cancer in this population and suggest the necessity to improve the genetic cancer risk assessment. Furthermore, the identification of the most frequent mutations of \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e and \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e in the population of Burkina Faso will allow the development of an inexpensive genetic test for the identification of subjects at high genetic cancer risk, which could be used to design personalized therapeutic protocols.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "365"
  ],
  "article-number": "65",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "9 July 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "17 October 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "30 October 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "This work has been approved by the Ethical Committee for Health Research of Burkina Faso N° 2014-8-098. Each subject enrolled in the study signed a written informed consent. The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Biancolella",
      "given": "Michela",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Ouédraogo",
      "given": "Nabonswindé Lamoussa Marie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zongo",
      "given": "Nayi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zohoncon",
      "given": "Théodora Mahoukèdè",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Testa",
      "given": "Barbara",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rizzacasa",
      "given": "Barbara",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Latini",
      "given": "Andrea",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Conte",
      "given": "Chiara",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Compaore",
      "given": "Tégwindé Rebeca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ouedraogo",
      "given": "Charlemagne Marie Rayang-Newendé",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Traore",
      "given": "Si Simon",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Simpore",
      "given": "Jacques",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-7781-602X",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Novelli",
      "given": "Giuseppe",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        10,
        30
      ]
    ],
    "date-time": "2021-10-30T18:02:43Z",
    "timestamp": 1635616963000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        10,
        30
      ]
    ],
    "date-time": "2021-10-30T18:04:04Z",
    "timestamp": 1635617044000
  },
  "funder": [
    {
      "name": "pietro annigoni association"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        29
      ]
    ],
    "date-time": "2024-03-29T04:39:49Z",
    "timestamp": 1711687189622
  },
  "is-referenced-by-count": 9,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        10,
        30
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2021,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            30
          ]
        ],
        "date-time": "2021-10-30T00:00:00Z",
        "timestamp": 1635552000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            30
          ]
        ],
        "date-time": "2021-10-30T00:00:00Z",
        "timestamp": 1635552000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00365-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-021-00365-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00365-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2021,
        10,
        30
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        10,
        30
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/caac.21492",
      "author": "F Bray",
      "doi-asserted-by": "publisher",
      "journal-title": "CA Cancer J Clin",
      "key": "365_CR1",
      "unstructured": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre AL, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. https://doi.org/10.3322/caac.21492.",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S0140-6736(18)32252-9",
      "doi-asserted-by": "publisher",
      "key": "365_CR2",
      "unstructured": "The Lancet. GLOBOCAN 2018: counting the toll of cancer. Lancet. 2018; https://doi.org/10.1016/S0140-6736(18)32252-9."
    },
    {
      "key": "365_CR3",
      "unstructured": "Ferlay J, Ervik M, and Lam F, et al. Global cancer observatory: cancer today. In: Lyon, France: International Agency for Research on Cancer. 2018. https://gco.iarc.fr/today."
    },
    {
      "author": "International Agency for Research on Cancer",
      "first-page": "1",
      "journal-title": "IARC Sci Publ",
      "key": "365_CR4",
      "unstructured": "International Agency for Research on Cancer. Cancer in Africa: epidemiology and prevention. IARC Sci Publ. 2003;153:1–414.",
      "volume": "153",
      "year": "2003"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-14-0281",
      "author": "DM Parkin",
      "doi-asserted-by": "publisher",
      "first-page": "953",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "365_CR5",
      "unstructured": "Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev. 2014;23:953–66. https://doi.org/10.1158/1055-9965.EPI-14-0281.",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s12992-018-0446-6",
      "author": "E Black",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Global Health",
      "key": "365_CR6",
      "unstructured": "Black E, Richmond R. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward. Global Health. 2019;15:3–4.",
      "volume": "15",
      "year": "2019"
    },
    {
      "DOI": "10.1080/20742835.2017.1391467",
      "author": "SN Cumber",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "Southern Afr J Gynaecol Oncol",
      "key": "365_CR7",
      "unstructured": "Cumber SN, Nchanji KN, Tsoka-Gwegweni JM. Breast cancer among women in sub-Saharan Africa: prevalence and a situational analysis. Southern Afr J Gynaecol Oncol. 2017;9:35–7.",
      "volume": "9",
      "year": "2017"
    },
    {
      "DOI": "10.1515/bmc-2019-0015",
      "doi-asserted-by": "publisher",
      "key": "365_CR8",
      "unstructured": "Sagna T, Bonora E, Ouedraogo MNL, Fusco D, Zoure AA, Bisseye C, et al. Identification of BRCA1/2 p.Ser1613Gly, p.Pro871Leu, p.Lys1183Arg, p.Glu1038Gly, p.Ser1140Gly, p.Ala2466Val, p.His2440Arg variants in women under 45 years old with breast nodules suspected of having breast cancer in Burkina Faso. Biomol Concepts. 2019;10:120–7. https://doi.org/10.1515/bmc-2019-0015."
    },
    {
      "author": "AA Zouré",
      "first-page": "7",
      "journal-title": "Afr J Biomed Res",
      "key": "365_CR9",
      "unstructured": "Zouré AA, Bambara HA, Sawadogo AY, Bakri Y, Simporé J. BRCA1 and BRCA2 gene mutations in breast cancer among West African women. Afr J Biomed Res. 2018;21:7–10.",
      "volume": "21",
      "year": "2018"
    },
    {
      "DOI": "10.1017/gheg.2018.8",
      "author": "A Abbad",
      "doi-asserted-by": "publisher",
      "journal-title": "Glob Health Epidemiol Genom",
      "key": "365_CR10",
      "unstructured": "Abbad A, Baba H, Dehbi H, Elmessaoudi-Idrissi M, Elyazghi Z, Abidi O, et al. Genetics of breast cancer in African populations: a literature review. Glob Health Epidemiol Genom. 2018. https://doi.org/10.1017/gheg.2018.8.",
      "year": "2018"
    },
    {
      "DOI": "10.4081/jphia.2018.663",
      "doi-asserted-by": "publisher",
      "key": "365_CR11",
      "unstructured": "Zoure AA, Slaoui M, Bambara HA, Sawadogo AY, Compaoré TR, Ouédraogo NLM, et al. BRCA1 c.68_69delAG (exon2), c.181T\u003eG (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso. J Public Health Afr. 2018;9:663. https://doi.org/10.4081/jphia.2018.663."
    },
    {
      "key": "365_CR12",
      "unstructured": "Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiyae A, editors. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993–2021."
    },
    {
      "DOI": "10.1126/science.7545954",
      "author": "Y Miki",
      "doi-asserted-by": "publisher",
      "first-page": "66",
      "journal-title": "Science",
      "key": "365_CR13",
      "unstructured": "Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71. https://doi.org/10.1126/science.7545954.",
      "volume": "266",
      "year": "1994"
    },
    {
      "DOI": "10.1038/378789a0",
      "author": "R Wooster",
      "doi-asserted-by": "publisher",
      "first-page": "789",
      "journal-title": "Nature",
      "key": "365_CR14",
      "unstructured": "Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–92. https://doi.org/10.1038/378789a0.",
      "volume": "378",
      "year": "1995"
    },
    {
      "DOI": "10.1002/humu.23406",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "593",
      "journal-title": "Hum Mutat",
      "key": "365_CR15",
      "unstructured": "Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, et al. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat. 2018;39:593–620.",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.1002/humu.20319",
      "author": "X Chen",
      "doi-asserted-by": "publisher",
      "first-page": "427",
      "journal-title": "Hum Mutat",
      "key": "365_CR16",
      "unstructured": "Chen X, Truong T-TN, Weaver J, Bove BA, Cattie K, Armstrong BA, et al. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum Mutat. 2006;27:427–35.",
      "volume": "27",
      "year": "2006"
    },
    {
      "DOI": "10.1002/cncr.29645",
      "author": "C Phelan",
      "doi-asserted-by": "publisher",
      "first-page": "4173",
      "journal-title": "Cancer",
      "key": "365_CR17",
      "unstructured": "Phelan C, Servais L, Kim J, Narod SA, Akbari MR, Vadaparampil ST. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer. 2015;121:4173–80. https://doi.org/10.1002/cncr.29645.",
      "volume": "121",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41598-021-94403-1",
      "author": "H Abdel-Razeq",
      "doi-asserted-by": "publisher",
      "first-page": "14906",
      "journal-title": "Sci Rep",
      "key": "365_CR18",
      "unstructured": "Abdel-Razeq H, Abujamous L, Abunasser M, Edaily S, Bater R. Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan. Sci Rep. 2021;11:14906. https://doi.org/10.1038/s41598-021-94403-1.",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.1038/gim.2015.166",
      "author": "LR Susswein",
      "doi-asserted-by": "publisher",
      "first-page": "823",
      "journal-title": "Genet Med",
      "key": "365_CR19",
      "unstructured": "Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L, et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med. 2016;18:823–32.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ijc.27326",
      "author": "JD Fackenthal",
      "doi-asserted-by": "publisher",
      "first-page": "1114",
      "journal-title": "Int J Cancer",
      "key": "365_CR20",
      "unstructured": "Fackenthal JD, Zhang J, Zhang B, Zheng Y, Hagos F, Burrill DR, et al. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. Int J Cancer. 2012;131:1114–23. https://doi.org/10.1002/ijc.27326.",
      "volume": "131",
      "year": "2012"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "365_CR21",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24. https://doi.org/10.1038/gim.2015.30.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0225039",
      "author": "P Ssentongo",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "365_CR22",
      "unstructured": "Ssentongo P, Lewcun JA, Candela X, Ssentongo AE, Kwon EG, Ba DM, et al. Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: a systematic review and meta-analysis. PLoS ONE. 2019;14: e0225039. https://doi.org/10.1371/journal.pone.0225039.",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jama.294.15.1925",
      "author": "R Nanda",
      "doi-asserted-by": "publisher",
      "first-page": "1925",
      "journal-title": "JAMA",
      "key": "365_CR23",
      "unstructured": "Nanda R, Schumm LP, Cummings S, Fackenthal JD, Seven L, Ademuyiwa F, et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA. 2005;294:1925–33. https://doi.org/10.1001/jama.294.15.1925.",
      "volume": "294",
      "year": "2005"
    },
    {
      "DOI": "10.1159/000351592",
      "author": "S Shkedi-Rafid",
      "doi-asserted-by": "publisher",
      "first-page": "174",
      "journal-title": "Public Health Genomics",
      "key": "365_CR24",
      "unstructured": "Shkedi-Rafid S, Ofer-Bialer G, Meiner V, Calderon-Margalit R. Clinicians’ attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations. Public Health Genomics. 2013;16:174–83. https://doi.org/10.1159/000351592.",
      "volume": "16",
      "year": "2013"
    },
    {
      "DOI": "10.1086/302511",
      "author": "HC Mefford",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "journal-title": "Am J Hum Genet",
      "key": "365_CR25",
      "unstructured": "Mefford HC, Baumbach L, Panguluri RC, Whitfield-Broome C, Szabo C, Smith S, et al. Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet. 1999;65:575–8. https://doi.org/10.1086/302511.",
      "volume": "65",
      "year": "1999"
    },
    {
      "DOI": "10.1136/jmedgenet-2017-104707",
      "author": "AE Toland",
      "doi-asserted-by": "publisher",
      "first-page": "721",
      "journal-title": "J Med Genet",
      "key": "365_CR26",
      "unstructured": "Toland AE, Andreassen PR. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment. J Med Genet. 2017;54:721–31. https://doi.org/10.1136/jmedgenet-2017-104707.",
      "volume": "54",
      "year": "2017"
    },
    {
      "DOI": "10.1002/humu.21628",
      "author": "AB Spurdle",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "Hum Mutat",
      "key": "365_CR27",
      "unstructured": "Spurdle AB, Healey S, Devereau A, Hogervorst FB, Monteiro AN, Nathanson KL, et al. ENIGMA-evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat. 2012;33:2–7. https://doi.org/10.1002/humu.21628.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1002/humu.20880",
      "author": "SE Plon",
      "doi-asserted-by": "publisher",
      "first-page": "1282",
      "journal-title": "Hum Mutat",
      "key": "365_CR28",
      "unstructured": "Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008;29:1282–91. https://doi.org/10.1002/humu.20880.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10549-010-1006-9",
      "author": "J Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "573",
      "journal-title": "Breast Cancer Res Treat",
      "key": "365_CR29",
      "unstructured": "Zhang J, Fackenthal JD, Huo D, Zheng Y, Olopade OI. Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population. Breast Cancer Res Treat. 2010;124:573–7. https://doi.org/10.1007/s10549-010-1006-9.",
      "volume": "124",
      "year": "2010"
    },
    {
      "DOI": "10.1186/s12885-019-5756-4",
      "author": "GN Tsaousis",
      "doi-asserted-by": "publisher",
      "first-page": "535",
      "journal-title": "BMC Cancer",
      "key": "365_CR30",
      "unstructured": "Tsaousis GN, Papadopoulou E, Apessos A, Agiannitopoulos K, Pepe G, Kampouri S, et al. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations. BMC Cancer. 2019;19:535. https://doi.org/10.1186/s12885-019-5756-4.",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1056/NEJMoa1913948",
      "doi-asserted-by": "publisher",
      "key": "365_CR31",
      "unstructured": "Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, et al. Breast cancer risk genes-association analysis in more than 113,000 women. N Engl J Med. 2021;384:428–39. https://doi.org/10.1056/NEJMoa1913948."
    },
    {
      "key": "365_CR32",
      "unstructured": "The Broad Institute and the Regents of the University of California. www.broadinstitute.org/igv."
    },
    {
      "key": "365_CR33",
      "unstructured": "The Human Genome Variation Society. http://www.hgvs.org."
    },
    {
      "key": "365_CR34",
      "unstructured": "The BRCA Exchange. https://brcaexchange.org/."
    },
    {
      "DOI": "10.1093/nar/gkx1153",
      "author": "MJ Landrum",
      "doi-asserted-by": "publisher",
      "first-page": "D1062",
      "journal-title": "Nucleic Acids Res",
      "key": "365_CR35",
      "unstructured": "Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062–7. https://doi.org/10.1093/nar/gkx1153.",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.1002/humu.21438",
      "doi-asserted-by": "crossref",
      "key": "365_CR36",
      "unstructured": "Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, and den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32:557–63."
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "365_CR37",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelinesfor the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nmeth0410-248",
      "author": "IA Adzhubei",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "journal-title": "Nat Methods",
      "key": "365_CR38",
      "unstructured": "Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nmeth.2890",
      "author": "JM Schwarz",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "journal-title": "Nat Methods",
      "key": "365_CR39",
      "unstructured": "Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2.",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41586-020-2308-7",
      "doi-asserted-by": "publisher",
      "key": "365_CR40",
      "unstructured": "Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581434–43. https://doi.org/10.1038/s41586-020-2308-7."
    }
  ],
  "reference-count": 40,
  "references-count": 40,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-021-00365-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}